@inproceedings{inproceedings, title  = {{Evaluation of tumour microenvironment identifies immune correlates of response to combination immunotherapy with margetuximab (M) and pembrolizumab (P) in HER2+gastroesophageal adenocarcinoma (GEA)}},

 url = {{}},

 year = {{2019}},

 month = {{10}},

 author = {{Rutella S and Church SE and Vadakekolathu J and Reeder S and Sullivan AH and Warren S and Baughman J and Muth J and Park H and Uronis H and Kang Y-K et al}},

 volume = {{30}},

 journal = {{ANNALS OF ONCOLOGY}},

 note = {{Accessed on 2026/02/25}}}